(PharmaNewsWire.Com, November 18, 2021 ) The oxygenated solvents market is estimated to grow from USD 22.28 billion in 2017to USD 32.27 billion by 2022, at a CAGR of 7.8%.Oxygenated solventshavestrong solvencyand volatility. Hence, these solventsare preferred in applications such as paints & coatings and personal care. The common types of oxygenated solvents include alcohols, ketones, esters, glycols,bio & green solvents and glycol esters. With the regulations on the use of volatile organic compounds (VOCs), the bio & green solvents typeisincreasingly preferred by endusers.
The bio &green solvents segment is projected to be the fastest-growing source segment during the forecast period. The use of renewable sources as raw materials, and non-toxic and environmental friendly nature of bio & green solvents are expected to boost the demand during the forecast period.
The glycol etherssegment is projected to be the fastest-growing type in the oxygenated solvents market.Glycol ethersolvents possess low vapor pressures and are exempted from VOC-regulations. Furthermore, the non-toxic nature of these solvents enables them to be used in applications such as pharmaceuticals and crop-protection.
The crop protectionsegment is projected to be the fastest-growing application of oxygenated solvents during the forecast period. Increasing food demand and cultivable lands is expected to drive the market for oxygenated solvents in this segment.
Asia-Pacific is projected to be the fastest-growing market for oxygenated solvents globally. The increaseddemand for oxygenated solventsfrom Asia-Pacificcan beattributed to the shifting of the manufacturing sector from North America and Europeto Asia-Pacific. Moreover, increased government spending on the agricultural and building & construction sectorsin the region is also fueling the growth of the oxygenated solvents market.
The demand for conventional oxygenated solvents is driven by the low crude oil prices. In case of bio & green solvents, regulations on the VOC emissions are expected to drive the market.The major players in the market have presence in high growth markets such as Asia-Pacific and Middle East & Africa, which serve the market players with better opportunities.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: